ConductScience.org, home
Genes
API referenceFor AI assistants

Gene · 100048912

CDKN2B-AS1: CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CDKN2B-AS1: CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1. Genes, record 100048912. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100048912

On this page

Gene

Symbol
CDKN2B-AS1
HGNC
Name
CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1
HGNC
NCBI Gene ID
100048912
NCBI Gene
HGNC ID
HGNC:34341
HGNC
Ensembl
ENSG00000240498
NCBI Gene
Aliases
66CTG, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, RP11-145E5.4, p15AS
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,649

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCDKN2B-AS1 papersNewest fiscal year
P30DK063491Diabetes Research Center (DRC)112025
P30EY014104P30 Core Grant for Vision Research102025
R01EY022305NEIGHBORHOOD Consortium for POAG Genetics102025
P30CA016672Cancer Center Support Grant92025
R01HL086694From GWAS loci to blood pressure genes, variants & mechanisms - Renewal82025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging82025
R01EY013178Novel Glaucoma Diagnostics for Structure and Function.62025
R01HL148239Multimodal genetic regulatory architecture of coronary artery disease52025
P01CA214091Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies42025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)42025

1 to 10 of 1,649Source NIH's project files

See all 1,649 nih grants

Papers3,196

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Pro-inflammatory and autophagic pathways in lung cancer: dysregulation of key genes ADINR, C/EBPα, CHAST, ATG5, IL-1B, and DICER1-AS1.Biochem Biophys Rep202642741253PubTator, text miningPubMed
Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.
Front Cardiovasc Med202642662925PubTator, text miningPubMed
Statement of Retraction: The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis.J Recept Signal Transduct Res202642639709PubTator, text miningPubMed
A Whole-Genome Sequence Genome-Wide Association Study in All of Us Identifies a Novel Glaucoma Risk Locus in African Individuals.Ophthalmol Sci202642620341PubTator, text miningPubMed
Retraction: Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-1/ Smad signaling pathway.Cancer Biomark202642543497PubTator, text miningPubMed
The Role of Long Non-Coding RNAs in the Pathogenesis of Coronary Heart Disease.Genes (Basel)202642510847PubTator, text miningPubMed
Half-Life as a Therapeutic Design Axis: Targeting Short-Lived lncRNAs With Antisense Oligonucleotides.IUBMB Life202642432430PubTator, text miningPubMed
Associations of MALAT1 rs619586/rs3200401 and ANRIL rs10965215/rs10738605 polymorphisms with type 2 diabetes and diabetic nephropathy risk in an Egyptian population.Front Endocrinol (Lausanne)202642428670PubTator, text miningPubMed
Inflammation and RNA-Related Polymorphisms in Resected Cholangiocarcinoma: Prognostic Associations in Intrahepatic and Perihilar Tumors.J Gastrointest Cancer202642418091PubTator, text miningPubMed
Hyaluronic acid-functionalized Fe3O4 nanoparticles loaded with trans-chalcone: in vitro anticancer activity and lncRNA modulation in hepatocellular carcinoma cells.Sci Rep202642401688PubTator, text miningPubMed

1 to 10 of 3,196

See all 3,196 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/100048912

GET https://conductscience.org/api/genes/v1/100048912/grants?page=2

API referenceFor AI assistants